Investors & Media

SEC Filing Details

Investors & Media

SEC Filing Details

Document Details

Form
4
Filing Date
Dec 14, 2022
Document Date
Dec 12, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Day One Biopharmaceuticals, Inc.
Issuer
DAY ONE BIOPHARMACEUTICALS, INC.
Filer
Atlas Venture Fund XI, L.P.
Investor Contact

Investor Relations
investors@dayonebio.com

Media Contact

Laura Cooper
Media@dayonebio.com

Helpful Tools